News
Posted
All
| 2019 | 2018 | 2017 | 2016
Access to Care May Reduce Cancer Disparities
When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show. The study results are published in JAMA Network Open by a team... Read More
POSTED: 08/17/2018SOURCE: SWOG News
Volume 9, Issue 3 Dear Colleague, The summer issue of Nutrition Frontiers showcases vitamin D-related genetic variation and cancer risk, the therapeutic potential of zerumbone, a ginger extract, against hepatocellular... Read More
POSTED: 08/02/2018SOURCE: DCP News
The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr. Judith Paice
Pain is a common symptom in cancer patients. It can be caused by cancer, its treatments, or a combination of factors. Although some pain lasts a relatively short time and will resolve on its own, cancer or its treatments can... Read More
POSTED: 07/16/2018SOURCE: NCI Cancer Currents Blog
NCI and VA collaborate to boost veterans’ access to cancer clinical trials
Veterans with cancer who receive treatment from the Department of Veterans Affairs (VA) will now have easier access to clinical trials of novel cancer treatments, thanks to an agreement between VA and the National Cancer... Read More
POSTED: 07/10/2018SOURCE: NCI Press Release
Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents
Health care providers should emphasize cancer prevention when discussing human papillomavirus (HPV) vaccination with the parents of preteens who are due to receive the vaccine. That’s the conclusion of a new study that asked... Read More
POSTED: 07/10/2018SOURCE: NCI Cancer Currents Blog
The NCI Community Oncology Research Program (NCORP) issued three funding opportunity announcements; one each for Community Sites, Minority/Underserved Community Sites, and Research Bases. In addition, the program announced... Read More
POSTED: 06/25/2018SOURCE: DCP News
Finasteride Safe, Long-Term Results Show
Twenty five years after it opened for enrollment, the landmark Prostate Cancer Prevention Trial has delivered a final verdict. Finasteride, a common hormone-blocking drug, reduces men's risk of getting prostate cancer... Read More
POSTED: 05/21/2018SOURCE: SWOG News
Volume 9, Issue 2 Dear Colleague, The spring issue of Nutrition Frontiers showcases the association of gut microbial communities in premenopausal women, how high-fat, high-calorie-diet-induced obesity may increase... Read More
POSTED: 05/14/2018SOURCE: DCP News
The NCI Cancer Prevention Fellowship Program (CPFP), which supports postdoctoral research and leadership training, is accepting applications for the fellows’ class that starts in 2019. The application period is open until... Read More
POSTED: 05/10/2018SOURCE: DCP News
Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers
Researchers have shown that an experimental screening test can detect some endometrial and ovarian cancers at their early, more treatable stages. The test, called PapSEEK, is a type of liquid biopsy that identifies cancer-... Read More
POSTED: 05/02/2018SOURCE: NCI Cancer Currents Blog
Division of Cancer Prevention Director Barry Kramer, MD, MPH, answers questions about cancer overdiagnosis. Q: What is cancer overdiagnosis? A: Cancer overdiagnosis is the detection of asymptomatic cancers, often through... Read More
POSTED: 04/23/2018SOURCE: DCP News
The Finding Cancer Trials Collaborative
Imagine a day when a cancer patient can find relevant cancer clinical trials with ease. We invite the entire cancer community – including patients, advocates, clinical trialists, industry, and NCI – to achieve this vision... Read More
POSTED: 04/16/2018SOURCE: NCI Clinical Trials Reporting Program News
The Finding Cancer Trials Collaborative
Imagine a day when a cancer patient can find relevant cancer clinical trials with ease. We invite the entire cancer community – including patients, advocates, clinical trialists, industry, and NCI – to achieve this vision... Read More
POSTED: 04/16/2018SOURCE:
The PREVENT Cancer Preclinical Drug Development Program (PREVENT) is a peer-reviewed program designed to support development of the best ideas in cancer prevention using National Cancer Institute contract resources. The... Read More
POSTED: 04/13/2018SOURCE: DCP News
Interactive App Improves Colorectal Cancer Screening Rates
Although screening for colorectal cancer has been shown to decrease deaths from the disease, only about two-thirds of Americans are up to date with screening. Now a new study suggests that giving people an easy way to order... Read More
POSTED: 04/09/2018SOURCE: NCI Cancer Currents Blog
NCI Launches New Resource for Specimens and Data from Cancer Clinical Trials
NCI announced the launch today of a new resource for cancer researchers interested in conducting studies using specimens and clinical data collected from cancer treatment trials in NCI’s National Clinical Trials Network (... Read More
POSTED: 04/02/2018SOURCE: NCI Cancer Currents Blog
Higher Risk of Heart Failure Seen in Some Cancers
Some people who have been treated for breast cancer or lymphoma have a higher risk of developing congestive heart failure than people who haven't had cancer, results from a new study show. Read More
POSTED: 03/26/2018SOURCE: NCI Cancer Currents Blog
Cervical cancer is the fourth most common cancer in women worldwide, with over 500,000 new cases estimated each year. Although the global burden is great, it is not equally distributed between nations – more than 85% of... Read More
POSTED: 02/27/2018SOURCE: CGH Spotlight Blog
Volume 9, Issue 1 Dear Colleague, The winter issue of Nutrition Frontiers showcases the chemopreventive activity of sulforaphane, how a high fat, high cholesterol diet may impact hepatocellular carcinoma, and p53... Read More
POSTED: 02/14/2018SOURCE: DCP News
Study Identifies Potential Cause of Hearing Loss from Cisplatin
Results from a new study may explain why many patients treated with the chemotherapy drug cisplatin develop lasting hearing loss. Researchers found that, in both mice and humans, cisplatin can be found in the cochlea—the... Read More
POSTED: 01/26/2018SOURCE: NCI Cancer Currents Blog
The Challenging Landscape of Cancer and Aging: Charting a Way Forward
Earlier this month, I had the privilege of giving two scientific talks: one at a Grand Rounds lecture hosted by NCI’s Center for Cancer Research, and a second held at the Sidney Kimmel Comprehensive Cancer Center at Johns... Read More
POSTED: 01/24/2018SOURCE: NCI Cancer Currents Blog
Acupuncture May Reduce Treatment-Related Joint Pain for Breast Cancer Patients
Acupuncture can reduce joint pain caused by drugs called aromatase inhibitors, according to results from a large, rigorous study of this approach in postmenopausal women with early-stage breast cancer.Read the article Read More
POSTED: 01/08/2018SOURCE: NCI Cancer Currents Blog
In the largest, most rigorous study of its kind, acupuncture was found to significantly reduce the debilitating joint pain experienced by tens of thousands of women each year while being treated for early stage breast... Read More
POSTED: 12/07/2017SOURCE: DCP News
Questions at the heart of the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) were highlighted in recent media coverage. The large NCI-funded trial administered by NCORP research base ECOG-ACRIN, is comparing... Read More
POSTED: 12/07/2017SOURCE: DCP News
Experimental Ovarian Cancer Vaccine Shows Promise in Mice
In mouse studies, an experimental vaccine strategy has shown promise for preventing ovarian cancer. The vaccine targets a protein that is present at elevated levels in approximately 90% of human ovarian epithelial cancers,... Read More
POSTED: 11/17/2017SOURCE: NCI Cancer Currents Blog